Abnormal Hdl3a Concentration C5139337
Abnormal levels of HDL3a, a smaller form of "good" cholesterol. This finding may indicate metabolic disturbances affecting lipid processing. Appropriate management focuses on diet, exercise, and controlling underlying conditions.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest pain at rest
Sharp or crushing chest pain occurring while at rest, not related to physical activity.
This is a medical emergency - call emergency services immediately
Sudden cardiac event
Unexpected heart-related emergency including heart attack or cardiac arrest symptoms.
This is a life-threatening emergency - call emergency services immediately
Fatigue
(constitutional)Persistent tiredness and lack of energy that is not relieved by rest.
Frequency: 60-70% of patients
Chest discomfort
(cardiovascular)Mild pressure, tightness, or squeezing sensation in the chest area.
Frequency: 30-40% of patients
Xanthomas
(dermatologic)Frequency: 10-15% of patients
Unexplained weight gain
(constitutional)Increased body weight, particularly around the abdomen, without significant dietary changes.
Frequency: 40-50% of patients
Memory difficulties
(neurologic)Mild cognitive changes including trouble concentrating or remembering details.
Frequency: 15-20% of patients
Shortness of breath
(cardiovascular)Difficulty breathing or feeling winded with minimal exertion.
Frequency: 25-35% of patients
Abdominal discomfort
(gastrointestinal)Generalized pain or fullness in the abdominal region, often after eating.
Frequency: 15-20% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Smoking Cessation
Complete cessation of tobacco use is essential as smoking damages HDL particles and significantly impairs their cardioprotective functions, including the HDL3a subfraction which is particularly vulnerable to oxidative modification.
Soluble Fiber Enrichment
Increased consumption of soluble fiber from sources such as oats, barley, legumes, and psyllium husk helps improve HDL3a concentrations by reducing cholesterol absorption and enhancing bile acid excretion.
Additional treatment options
Structured Physical Activity Program
Regular physical activity including both aerobic exercises and resistance training promotes favorable changes in HDL subfraction distribution and enhances overall cardiovascular health markers.
physical_therapyCardiovascular Risk Assessment
Comprehensive cardiovascular risk evaluation including family history, blood pressure monitoring, and lipid subfraction analysis to guide treatment intensity and follow-up frequency.
monitoringModerate Alcohol Consumption Reduction
Limiting alcohol intake to moderate levels, if consumed, helps maintain optimal HDL3a concentrations as excessive alcohol can negatively alter HDL subfraction composition and function.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Hdl3a Concentration C5139337?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019.
Rohrer L, Hersberger M, von Eckardstein A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol. 2022.
Nagai Y, Takase H, Tsuchiya Y, et al. Effects of evacetrapib on HDL subfractions and cholesterol efflux capacity in patients with dyslipidemia. J Clin Lipidol. 2021.
Di X, Tang X, Liu J, et al. HDL3-C concentration and cardiovascular risk: a systematic review and meta-analysis of prospective studies. Eur J Prev Cardiol. 2023.
Medication Comparisons
Compare medications used to treat Abnormal Hdl3a Concentration C5139337. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy